Reversible pegylation of insulin facilitates its prolonged action in vivo
- 7 April 2008
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 70 (1) , 19-28
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Prolonging the Action of Protein and Peptide Drugs by a Novel Approach of Reversible Polyethylene Glycol ModificationJournal of Biological Chemistry, 2004
- Peptide and protein PEGylationBiomaterials, 2001
- A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivoDrugs of the Future, 2001
- Effect of Fatty Acids and Selected Drugs on the Albumin Binding of a Long-Acting, Acylated Insulin AnalogueJournal of Pharmaceutical Sciences, 1997
- Albumin Binding and Time Action of Acylated Insulins in Various SpeciesJournal of Pharmaceutical Sciences, 1996
- Preparation and application of radioiodinated sulfhydryl reagents for the covalent labeling of SH-proteins present in minute quantitiesJournal of Biochemical and Biophysical Methods, 1992
- Effect of Raising Injection-Site Skin Temperature on Isophane (NPH) Insulin Crystal DissociationDiabetes Care, 1989
- Evaluation of factors responsible for the inability of insulin to antagonize lipolysis due to high concentrations of catecholaminesBiochemical and Biophysical Research Communications, 1982
- Absorption of isophane (NPH) insulin and its clinical implications.BMJ, 1982
- Receptor-binding region of insulinNature, 1976